CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: BYR-67805 | Pharmaceuticals and Healthcare
Historical data: 2017 - 2023
Forecast period: 2025 - 2031
Quantitative units: Revenue in USD million and CAGR from 2025 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Cell and Advanced Therapies Supply Chain Management Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET
7.1 GLOBAL CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE (2017 - 2031) (USD MILLION)
8.1 GLOBAL CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
8.2 GLOBAL CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
9.1 GLOBAL CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
9.2 GLOBAL CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
10.1 GLOBAL CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY REGION (2017 - 2023) (USD MILLION)
10.2 GLOBAL CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY REGION (2025 - 2031) (USD MILLION)
11.1 NORTH AMERICA CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
11.2 NORTH AMERICA CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
11.3 NORTH AMERICA CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
11.4 NORTH AMERICA CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
11.5 NORTH AMERICA CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
11.6 NORTH AMERICA CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
12.1 EUROPE CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
12.2 EUROPE CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
12.3 EUROPE CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
12.4 EUROPE CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
12.5 EUROPE CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
12.6 EUROPE CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
13.1 ASIA PACIFIC CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
13.2 ASIA PACIFIC CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
13.3 ASIA PACIFIC CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
13.4 ASIA PACIFIC CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
13.5 ASIA PACIFIC CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
13.6 ASIA PACIFIC CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
14.1 LATIN AMERICA CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)/p>
14.2 LATIN AMERICA CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
14.3 LATIN AMERICA CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
14.4 LATIN AMERICA CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
14.5 LATIN AMERICA CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
14.6 LATIN AMERICA CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031)< (USD MILLION)/p>
16.1 Be The Match BioTherapies
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Brooks Life Sciences
16.3 Clarkston Consulting
16.4 Cryoport
16.5 Haemonetics
16.6 Hypertrust Patient Data Care
16.7 Lykan Bioscience
16.8 MAK-SYSTEM
16.9 MasterControl
16.10 SAP
16.11 SAVSU Technologies
16.12 sedApta Group
16.13 Stafa Cellular Therapy
16.14 Title21 Health Solutions
16.15 TraceLink
16.16 TrakCel
16.17 Vineti
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
By TypeCloud
On-premises
By Application
Biobank
Cell Therapy Lab
Hospital
Research Institute
Commercial Organization
Companies
Be The Match BioTherapies
Brooks Life Sciences
Clarkston Consulting
Cryoport
Haemonetics
Hypertrust Patient Data Care
Lykan Bioscience
MAK-SYSTEM
MasterControl
SAP
SAVSU Technologies
sedApta Group
Stafa Cellular Therapy
Title21 Health Solutions
TraceLink
TrakCel
Vineti
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.